Cas 722522-13-6,2-chloro-6-(2-hydroxy-5-chlorobenzylamino)purine riboside

722522-13-6

Post Buying Request

Basic information

Product Name: 2-chloro-6-(2-hydroxy-5-chlorobenzylamino)purine riboside
Synonyms: 2-chloro-6-(2-hydroxy-5-chlorobenzylamino)purine riboside
CAS NO:722522-13-6
Molecular Formula:
Molecular Weight: 442.258
EINECS: N/A
Product Categories: N/A
Mol File: 722522-13-6.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-chloro-6-(2-hydroxy-5-chlorobenzylamino)purine riboside(CAS DataBase Reference)
NIST Chemistry Reference: 2-chloro-6-(2-hydroxy-5-chlorobenzylamino)purine riboside(722522-13-6)
EPA Substance Registry System: 2-chloro-6-(2-hydroxy-5-chlorobenzylamino)purine riboside(722522-13-6)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 722522-13-6(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

722522-13-6 Suppliers

Recommended suppliersmore

722522-13-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 722522-13-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,2,5,2 and 2 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 722522-13:
(8*7)+(7*2)+(6*2)+(5*5)+(4*2)+(3*2)+(2*1)+(1*3)=126
126 % 10 = 6
So 722522-13-6 is a valid CAS Registry Number.

722522-13-6Upstream product

13276-52-3 2,6-dichloropurine riboside

722522-13-6Downstream Products

722522-13-6Relevant articles and documents

SUBSTITUTED 6-(BENZYLAMINO) PURINE RIBOSIDE DERIVATIVES, USE THEREOF AND COMPOSITIONS CONTAINING THESE DERIVATIVES

-

Page/Page column 25-26, (2010/12/17)

The invention relates to 2-substituted-6-(substituted benzylamino)purine riboside derivatives of the general formula I. These compounds possess antiapoptotic, anti-inflammatory and differentiating activities. The invention relates also to the compositions, which contain these derivatives as active ingredients. ˙

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 722522-13-6